# The Evaluation of Bepreve on the Measurement of Wheal and Flare Response From Histamine Skin Prick Testing

> **NCT01128556** · PHASE4 · COMPLETED · sponsor: **North Texas Institute for Clinical Trials** · enrollment: 30 (estimated)

## Conditions studied

- Histamine Responsive Allergy Patients

## Interventions

- **DRUG:** Bepreve
- **DRUG:** Refresh Tears

## Key facts

- **NCT ID:** NCT01128556
- **Lead sponsor:** North Texas Institute for Clinical Trials
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2010-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01128556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01128556, "The Evaluation of Bepreve on the Measurement of Wheal and Flare Response From Histamine Skin Prick Testing". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01128556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*